# Tazemetostat Hydrobromide Tablets 200mg (タズベリク錠２００ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4291073F1029). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4291073F1029
- **Product name (Japanese):** タズベリク錠２００ｍｇ
- **English title:** Tazemetostat Hydrobromide Tablets 200mg
- **Active ingredient:** タゼメトスタット臭化水素酸塩
- **Active ingredient (INN):** Tazemetostat Hydrobromide
- **Strength / unit:** ２００ｍｇ１錠
- **Route:** Oral (内用薬)
- **Therapeutic category:** 42 Antineoplastics (腫瘍用薬) › 429 Other antineoplastics (その他の腫瘍用薬)
- **Manufacturer:** Eisai (エーザイ)
- **NHI price (reference only):** JPY 3004 per ２００ｍｇ１錠
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4291073F1029
- **JSON:** https://www.nifujipharma.com/api/drugs/4291073F1029

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Tazemetostat%20Hydrobromide%20Tablets%20200mg%20(%E3%82%BF%E3%82%BA%E3%83%99%E3%83%AA%E3%82%AF%E9%8C%A0%EF%BC%92%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%204291073F1029#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.
